News Image

IonOpticks' Custom Chromatography Column to Become Biognosys' Standard for High-Quality Proteomic Insights

Provided By PR Newswire

Last update: Dec 5, 2024

MELBOURNE, Australia and ZURICH, Dec. 5, 2024 /PRNewswire/ -- Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a global leader in mass spectrometry-based proteomics contract research services, announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns to support the standardisation of its research services platforms and enable deeper, reproducible proteome profiling.  

Read more at prnewswire.com

BRUKER CORP

NASDAQ:BRKR (2/21/2025, 8:04:13 PM)

After market: 50.5 -0.32 (-0.63%)

50.82

-2.1 (-3.97%)



Find more stocks in the Stock Screener

Follow ChartMill for more